United States
Rep Login: blueWire
Medtronic Cardiac Diagnostics & Monitoring – For Healthcare Professionals
Cardiac Diagnostics & Monitoring

For Healthcare Professionals

SEEQ & LINQ, frequent vs infrequent symptoms

The Syncope Challenge

  • Syncope accounts for 3-5% of ED visits and 1-3% of all hospital admissions1,2
  • Cardiac syncope carries a 6-month mortality rate of greater than 10%, and doubles the risk of death1
  • Syncope negatively impacts patient quality of life3,4
  • Diagnosing patients with infrequent symptoms using a conventional Holter monitor is unlikely, due to low symptom-ECG correlation1

Syncope's Impact on Quality of Life3,4

4-1-2-img-banner

Survival Rates With and Without Syncope1

4-1-3-img-banner


Unexplained Syncope Patient Selection Considerations

For syncope patients, the fainting frequency and severity of events should be considered when deciding between short-term monitoring with SEEQ MCT and long-term monitoring with Reveal LINQ ICM.

Decision Tree - Unexplained Syncope

NEXT: Short-Term Monitoring

NEXT: Long-Term Monitoring

References
  1. Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. September 19, 2002; 347(12):878-885.
  2. Edvardsson N, Frykman V, van Mechelin R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. February 2011;13(2):262-269.
  3. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44(10):1037-1043.
  4. Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB. Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med. April 1994;9(4):181-186.